UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer – Reuters


Investorplace.com

UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
Reuters
May 21 (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease
New Asthma Drug Generates Excitement For Patients — And Its MakerForbes
Antibody Gets High Marks for Asthma Control – MedPage TodayMedPage Today
Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa TrialScience 2.0
Investorplace.com –Fox Business –Nature World News
all 17 news articles »

View full post on asthma – Google News

Regeneron, Sanofi asthma drug seen as potential game changer – Reuters

Regeneron, Sanofi asthma drug seen as potential game changer
Reuters
(Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers
Monoclonal antibody appears effective and safe in asthma Phase IIa trialEurekAlert (press release)
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of PR Newswire (press release)

all 4 news articles »

View full post on asthma – Google News